Back to search

Università degli Studi di Torino

EPIGENETIC THERAPY FOR FRIEDREICH’S ATAXIA: A PHASE 1, FIRST IN MAN, ASCENDING DOSE CROSSOVER STUDY TO INVESTIGATE THE SAFETY, PHARMACOKINETICS AND PHARMACODYNAMICS OF RG2833 (A HISTONE DEACETYLASE INHIBITOR) IN ADULTS WITH FRIEDREICH’S ATAXIA

Degree

thesis:*
Grantor dc:publisher
Università degli Studi di Torino
Year dc:date
2018

Author and committee

dc:creator, dc:contributor.*
Authors dc:creator
  • Clerico, Marinella
  • De Mercanti, Stefania Federica

Subjects

dc:subject × 1

Rights

dc:rights
Statement dc:rights
  • info:eu-repo/semantics/openAccess
Language dc:language
eng

Identifiers

dc:identifier.*
OAI identifier oai:identifier
oai:iris.unito.it:2318/1995248

Chain of custody

source
Harvested from
Università di Torino
Base URL
iris.unito.it/oai/driver
Last updated
2026-07-24
Source record
OAI-PMH GetRecord
citation

Clerico, Marinella; De Mercanti, Stefania Federica. EPIGENETIC THERAPY FOR FRIEDREICH’S ATAXIA: A PHASE 1, FIRST IN MAN, ASCENDING DOSE CROSSOVER STUDY TO INVESTIGATE THE SAFETY, PHARMACOKINETICS AND PHARMACODYNAMICS OF RG2833 (A HISTONE DEACETYLASE INHIBITOR) IN ADULTS WITH FRIEDREICH’S ATAXIA. Università degli Studi di Torino, 2018. https://hdl.handle.net/2318/1995248